{"title":"Mental health and attitudes toward suicide amongst individuals with gender dysphoria in Iran.","authors":"Maryam Assareh, Vahid Rashedi, Mehrdad Eftekhar Ardebili, Razieh Salehian, Mohammadreza Shalbafan","doi":"10.3389/fpsyt.2024.1443638","DOIUrl":"https://doi.org/10.3389/fpsyt.2024.1443638","url":null,"abstract":"<p><strong>Introduction: </strong>Gender dysphoria (GD) is associated with profound mental health challenges, including heightened suicide risk. This study aimed to explore the mental health status and attitudes toward suicide among individuals with GD in Iran.</p><p><strong>Methods: </strong>A comprehensive assessment was conducted using three validated tools: the General Health Questionnaire (GHQ-28) to gauge emotional distress and psychological well-being, the Beck Depression Inventory (BDI-II) to evaluate the severity of depressive symptoms, and the Predicament Questionnaire (PQ) to measure attitudes toward suicide in the context of social crises.</p><p><strong>Results: </strong>Among the 78 participants, 43 (55.1%) were identified as experiencing significant mental health issues, while 21 (26.9%) were found to suffer from severe depression. The average PQ score was 57.92, which aligns with findings from similar populations in previous studies, highlighting a concerning trend in suicide-related attitudes. Further statistical analysis revealed significant correlations between psychological distress (GHQ-28 scores) and attitudes toward suicide (PQ scores), as well as between depressive symptoms (BDI-II scores) and suicide-related attitudes.</p><p><strong>Conclusions: </strong>These findings indicate a pervasive prevalence of psychological disorders, particularly depression, within this group, and underscore the strong association between depressive states and suicidal ideation. The study underscores the urgent need for targeted mental health interventions and comprehensive healthcare policies tailored to the specific needs of individuals with GD in Iran. Given the substantial mental health burden observed, particularly the risk of suicide, this research highlights the critical importance of integrating mental health care into broader support systems for this population.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1443638"},"PeriodicalIF":3.2,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychometric properties of the pain anxiety symptom scale among postoperative patients in Amol, Iran.","authors":"Hamid Sharif-Nia, Erika Sivarajan Froelicher, João Marôco, Esmaeil Hoseinzadeh, Sima Hejazi, Reza Fatehi, Poorya Nowrozi, Bita Mohammadi","doi":"10.3389/fpsyt.2024.1422346","DOIUrl":"10.3389/fpsyt.2024.1422346","url":null,"abstract":"<p><strong>Introduction: </strong>So far, the psychometric properties of the Persian version of the Pain Anxiety Symptom Scale have not been assessed in Iran. Therefore, this study was conducted to determine the validity and reliability of the Persian version of the Pain Anxiety Symptom Scale among a group of Iranian patients in Amol.</p><p><strong>Methods: </strong>This methodological study was conducted in 2023 with a sample of 400 postoperative patients from Amol, Iran, selected through convenience sampling. The dataset was divided into two groups of 200 for exploratory and confirmatory factor analyses. Construct validity was assessed using maximum likelihood exploratory factor analysis with Promax rotation, supported by Horn's parallel analysis and network analysis to visualize item relationships. Confirmatory factor analysis, convergent and discriminant validity was performed on the second dataset. Reliability was evaluated through various statistical measures, including Cronbach's alpha, McDonald's omega, average inter-item correlation coefficient, composite reliability, and maximal reliability (MaxR).</p><p><strong>Results: </strong>Among the 400 participants, the mean age was 44.38 years (SD = 13.49), with 152 (46.1%) being women and 178 (53.9%) men. Most participants (n = 268, 81.2%) had an education level lower than a diploma, and 93 individuals (28.2%) reported a history of surgery. The results of exploratory factor analysis with Promax rotation developed two factors accounting for 66.29% of the variance comprising 15 items. Also, after necessary modifications during confirmatory factor analysis, the final model was approved. As for reliability, the Cronbach's alpha, composite reliability, and MaxR for all constructs were greater than 0.7, demonstrating good internal consistency and construct reliability.</p><p><strong>Conclusion: </strong>According to the results, the Persian version of the Pain Anxiety Symptom Scale has a valid structure and acceptable reliability. This scale can be used by health professionals in many ways.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1422346"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in PsychiatryPub Date : 2024-12-06eCollection Date: 2024-01-01DOI: 10.3389/fpsyt.2024.1455343
Joakim Jakobsson, Anna Karlsson, Anders Håkansson, Björn Hofvander
{"title":"Mortality among individuals with substance use disorder-does violent criminal behavior have an impact?","authors":"Joakim Jakobsson, Anna Karlsson, Anders Håkansson, Björn Hofvander","doi":"10.3389/fpsyt.2024.1455343","DOIUrl":"10.3389/fpsyt.2024.1455343","url":null,"abstract":"<p><strong>Introduction: </strong>Understanding violent criminality and its impact on health and eventually the risk of premature mortality is important for efficient future interventions. This study aimed to explore the effect violent criminality had on premature mortality (i.e., death before the age of 65) among individuals with substance use disorders (SUDs).</p><p><strong>Methods: </strong>The cohort was created by identifying all Swedish patients diagnosed with SUD between the first of January 2013 and 31st of December 2014. The individuals were split into three age categories.</p><p><strong>Results: </strong>There were significant differences in standard mortality rates (SMR) in the cohort compared to the general Swedish population across the three age categories. We found differences between the SMRs for individuals convicted of violent and nonviolent crimes in the two younger age categories [age 15-29: violent crime (42.4) vs. non-violent crime (36.6), age 30-44: violent crime (28.0) vs. non-violent crime (23.0)]. A Cox regression analysis showed that each conviction of a violent crime increased the hazard ratio (HR) of premature mortality significantly [age 15-29; HR = 1.10 (95% CI: 1.04-1.17), age 30-44; HR =1.06 (95% CI: 1.03-1.09)]. After correcting for non-violent crimes, the increased risk only remained for the youngest group [HR = 1.06 (95% CI: 1.00-1.13)].</p><p><strong>Discussion: </strong>This study suggests that criminal behavior constitutes a proxy for the risk behaviors that increase the risk of premature mortality among young individuals with SUD even after controlling for confounders. Longitudinal studies, examining time-dependent risks and protective influences, are needed to explain the different pathways and processes leading to the amplified premature mortality in the groups.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1455343"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in PsychiatryPub Date : 2024-12-06eCollection Date: 2024-01-01DOI: 10.3389/fpsyt.2024.1478345
Marthe Johansen, Hanne Kilen Stuen, Eva Brekke, Camilla Bergsve Jensen, Anne Landheim
{"title":"A qualitative study of the experiences of young people with severe mental health problems and complex needs regarding youth flexible assertive community treatment.","authors":"Marthe Johansen, Hanne Kilen Stuen, Eva Brekke, Camilla Bergsve Jensen, Anne Landheim","doi":"10.3389/fpsyt.2024.1478345","DOIUrl":"10.3389/fpsyt.2024.1478345","url":null,"abstract":"<p><p>Youth Flexible Assertive Community Treatment (Youth Flexible ACT) is a service model for children and young people with severe mental health problems and complex needs aimed at providing integrated, continuous and holistic care. Studies on young people's experiences of Youth Flexible ACT or similar models are scarce. The present qualitative study aimed to explore and describe how young people with severe mental health problems and complex needs experience follow-up and treatment provided by Youth Flexible ACT teams. Semi-structured interviews were conducted with 14 young people (age range, 15-19 years) who were being followed up by a Youth Flexible ACT team. Qualitative content analysis was used, and the following two overarching themes characterizing the young people's experiences of follow-up and treatment provided by Youth Flexible ACT teams were identified: (1) trusting and collaborative relationships, and (2) organization matters. The participants experienced a more personal relationship with the staff, who behaved more like friends and paid attention to resources, interests, solutions and their context. The participants emphasized and valued components that coincided with the Youth Flexible ACT model, indicating a match between what the young people needed and wanted and what the model was supposed to provide. The team providing these relationships and youth-friendly and developmentally sensitive care appeared to be facilitated by how the service model was organized, with the teams being flexible and accessible while providing integrated, multifaceted help and systemic follow-up.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1478345"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11662976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in PsychiatryPub Date : 2024-12-06eCollection Date: 2024-01-01DOI: 10.3389/fpsyt.2024.1485957
Shasha Wu, Qing Jiang, Jinhui Wang, Daming Wu, Yan Ren
{"title":"Immune-related gene characterization and biological mechanisms in major depressive disorder revealed based on transcriptomics and network pharmacology.","authors":"Shasha Wu, Qing Jiang, Jinhui Wang, Daming Wu, Yan Ren","doi":"10.3389/fpsyt.2024.1485957","DOIUrl":"10.3389/fpsyt.2024.1485957","url":null,"abstract":"<p><strong>Background: </strong>Major depressive disorder (MDD) is a severe psychiatric disorder characterized by complex etiology, with genetic determinants that are not fully understood. The objective of this study was to investigate the pathogenesis of MDD and to explore its association with the immune system by identifying hub biomarkers using bioinformatics analyses and examining immune infiltrates in human autopsy samples.</p><p><strong>Methods: </strong>Gene microarray data were obtained from the Gene Expression Omnibus (GEO) datasets GSE32280, GSE76826, GSE98793, and GSE39653. Our approach included differential expression analysis, weighted gene co-expression network analysis (WGCNA), and protein-protein interaction (PPI) network analysis to identify hub genes associated with MDD. Subsequently, gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Cytoscape plugin CluGO, and Gene Set Enrichment Analysis (GSEA) were utilized to identify immune-related genes. The final selection of immune-related hub genes was determined through the least absolute shrinkage and selection operator (Lasso) regression analysis and PPI analysis. Immune cell infiltration in MDD patients was analyzed using CIBERSORT, and correlation analysis was performed between key immune cells and genes. The diagnostic accuracy of the identified hub genes was evaluated using receiver operating characteristic (ROC) curve analysis. Furthermore, we conducted a study involving 10 MDD patients and 10 healthy controls (HCs) meeting specific criteria to assess the expression levels of these hub genes in their peripheral blood mononuclear cells (PBMCs). The Herbal Ingredient Target Database (HIT) was employed to screen for herbal components that target these genes, potentially identifying novel therapeutic agents.</p><p><strong>Results: </strong>A total of 159 down-regulated and 51 up-regulated genes were identified for further analysis. WGCNA revealed 12 co-expression modules, with modules \"darked\", \"darkurquoise\" and \"light yellow\" showing significant positive associations with MDD. Functional enrichment pathway analysis indicated that these differential genes were associated with immune functions. Integration of differential and immune-related gene analysis identified 21 common genes. The Lasso algorithm confirmed 4 hub genes as potential biomarkers for MDD. GSEA analysis suggested that these genes may be involved in biological processes such as protein export, RNA degradation, and fc gamma r mediated cytotoxis. Pathway enrichment analysis identified three highly enriched immune-related pathways associated with the 4 hub genes. ROC curve analysis indicated that these hub genes possess good diagnostic value. Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) demonstrated significant expression differences of these hub genes in PBMCs between MDD patients and HCs. Immune infiltration analysis revealed significant correlations between immune cells, inc","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1485957"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nocturnal hypoxia in patients with sleep disorders: exploring its role as a mediator between neurotic personality traits and psychological symptoms.","authors":"Fei Jiang, Jinsong Huang, Lijun Fan, Xiaoyan Dong, Chunyan Yang, Wenzhu Zhou","doi":"10.3389/fpsyt.2024.1442826","DOIUrl":"10.3389/fpsyt.2024.1442826","url":null,"abstract":"<p><strong>Introduction: </strong>Sleep disorders often coexist with personality and psychological issues, alongside nocturnal hypoxia. This study investigates the potential mediating role of nocturnal hypoxia between personality traits and psychological symptoms in individuals with sleep disorders.</p><p><strong>Methods: </strong>A cohort comprising 171 participants reporting sleep disturbances was recruited from Dalian Seventh People's Hospital. Psychological symptoms were assessed using the Symptom Checklist-90-R (SCL-90-R), while personality traits were evaluated using the Eysenck Personality Questionnaire (EPQ). Nocturnal hypoxia status was determined through overnight polysomnography.</p><p><strong>Results: </strong>Mediation analysis, conducted using SPSS 23.0, demonstrated that the cumulative time of nocturnal peripheral oxygen saturation (SpO2) < 85% (T85) partially mediated the relationship between neuroticism and various psychological symptoms, including somatization (c=0.207, c'=0.164, a*b=0.043, proportion of mediation 20.8%), interpersonal sensitivity (c=0.360, c'=0.326, a*b=0.034, proportion of mediation 9.6%), depression (c=0.277, c'=0.234, a*b=0.042, proportion of mediation 15.3%), anxiety (c=0.240, c'=0.199, a*b=0.041, proportion of mediation 16.9%), hostility (c=0.241, c'=0.205, a*b=0.036, proportion of mediation 14.9%), phobic anxiety (c=0.271, c'=0.241, a*b=0.030, proportion of mediation 11.1%), and psychoticism (c=0.298, c'=0.266, a*b=0.032, proportion of mediation 10.8%).</p><p><strong>Discussion: </strong>These findings underscore the potential mediating role of nocturnal hypoxia in the association between neuroticism personality traits and psychological symptoms among individuals with sleep disorders. Our research holds considerable significance in advancing the quest for personalized treatments targeting psychological symptoms in individuals with sleep disorders.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1442826"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in PsychiatryPub Date : 2024-12-06eCollection Date: 2024-01-01DOI: 10.3389/fpsyt.2024.1389992
Petrin Redayani Lukman, Tjhin Wiguna, Diantha Soemantri, Sri Linuwih Menaldi, Sylvia Detri Elvira, Limas Sutanto, Tuti Wahmurti A Sapiie, Aria Kekalih, Reina Rahma Noviasari, Hukma Shabiyya Rizki, Kharisma Zatalini Giyani
{"title":"Psychometric properties of comprehensive cognitive, affective, and psychomotor competency assessment scales in psychodynamic psychotherapy for borderline personality disorder.","authors":"Petrin Redayani Lukman, Tjhin Wiguna, Diantha Soemantri, Sri Linuwih Menaldi, Sylvia Detri Elvira, Limas Sutanto, Tuti Wahmurti A Sapiie, Aria Kekalih, Reina Rahma Noviasari, Hukma Shabiyya Rizki, Kharisma Zatalini Giyani","doi":"10.3389/fpsyt.2024.1389992","DOIUrl":"10.3389/fpsyt.2024.1389992","url":null,"abstract":"<p><strong>Background: </strong>Psychodynamic psychotherapy is a type of psychotherapy for individuals with borderline personality disorder (BPD). However, competency in conducting effective psychodynamic psychotherapy for BPD is difficult to evaluate. Therefore, this study aimed to identify the psychometric properties of a comprehensive scale to assess cognitive, affective, and psychomotor competencies (CS-CAPC) in psychodynamic psychotherapy for BPD.</p><p><strong>Methods: </strong>This is a qualitative study. The first step used the Delphi technique to gather experts' opinions on the cognitive, affective, and psychomotor competencies necessary to conduct psychodynamic psychotherapy for BPD. The experts comprised three psychotherapists, seven psychiatrists with experience in psychotherapy, and nine teaching staff. A panel discussion was conducted to obtain qualitative data. Thematic data analysis was adopted, and content validity testing was used to analyze the content validity of the CS-CAPC in psychodynamic psychotherapy for BPD.</p><p><strong>Results: </strong>The CS-CAPC comprised two scales assessing two specific competencies in psychodynamic psychotherapy for BPD: The first scale, the psychodynamic formulation competency assessment scale (PF-CAS), comprised six items, including the case description, etiology, and potential course of therapy. The second scale, the practical-competency assessment scale (PC-CAS) for psychodynamic psychotherapy for BPD, comprised 12 items, including building a therapeutic alliance, performing psychodynamic interventions while working through the therapeutic process, and closing the session. The scale-level content validity index (S-CVI) for the PF-CAS was 0.981, and that for the PC-CAS in psychodynamic psychotherapy for BPD was 1.00.</p><p><strong>Conclusion: </strong>The CS-CAPC in psychodynamic psychotherapy for BPD had good validity in assessing individual competency in the cognitive, affective, and psychomotor domains.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1389992"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in PsychiatryPub Date : 2024-12-06eCollection Date: 2024-01-01DOI: 10.3389/fpsyt.2024.1474558
Steve F Bierman, Andrew Weil, Stephen Dahmer
{"title":"Placebo and the law of identification.","authors":"Steve F Bierman, Andrew Weil, Stephen Dahmer","doi":"10.3389/fpsyt.2024.1474558","DOIUrl":"10.3389/fpsyt.2024.1474558","url":null,"abstract":"<p><p>Thousands of essays and studies have been published on placebo and nocebo. Yet, despite this plethora of information, we are not much closer to a comprehensive understanding of the fundamental mechanism producing placebo and nocebo effects than we were in 1946, when participants in the Cornell Conferences on Therapy speculated on the roles of authority, belief and expectancy. In this paper, we examine the weaknesses in current placebo and nocebo definitions and theories. We also propose a more concise and comprehensive definition and theory of placebo and nocebo by introducing the Law of Identification and the Generic Placebo Instruction (GPI). The latter being the placebo/nocebo information expressed or implied in virtually every clinical encounter and trial; the former (i.e., the Law of Identification), being what drives the GPI to actualization. Further, we demonstrate the explanatory power of this new theory and suggest clinical studies that test predictions arising from it - studies whose results, if positive, would translate universally into clinical practice.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1474558"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in PsychiatryPub Date : 2024-12-06eCollection Date: 2024-01-01DOI: 10.3389/fpsyt.2024.1490907
Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven Albert, Krista J Siefried, Jeffrey Guss
{"title":"Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.","authors":"Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven Albert, Krista J Siefried, Jeffrey Guss","doi":"10.3389/fpsyt.2024.1490907","DOIUrl":"10.3389/fpsyt.2024.1490907","url":null,"abstract":"<p><p>Methamphetamine (MA) dependence leads to severe physical and psychological issues. Current treatments, including psychosocial therapies and residential rehabilitation, face limitations such as high relapse rates, cost, and accessibility issues. As a result, there is an urgent need for novel approaches to treat MA dependence that are effective, affordable, and accessible to patients. Psilocybin, the active component in numerous mushrooms of the <i>Psilocybe</i> genus, has shown potential for enhancing psychotherapy for various addiction and mental health issues due to its effects on perception, cognition, and affect. Psilocybin-assisted psychotherapy (PAT) has demonstrated initial safety and efficacy in treating alcohol, cocaine, and nicotine dependence. The case presented here describes a 36-year-old transwoman and daily MA user, who participated in a single-arm open-label clinical trial assessing feasibility and safety of PAT for MA dependence at St. Vincent's Hospital, Sydney. Following inpatient withdrawal management and one session of psilocybin-assisted therapy, she experienced significant cognitive and emotional shifts and sustained MA abstinence. She reported improved mental health over 3 months following treatment completion. She also noted increased self-esteem, mindfulness, and distress tolerance. This study suggests that PAT (following inpatient MA withdrawal management) may offer a scalable, safe, and effective approach for treating MA dependence. However, further research is required to confirm the generalisability and efficacy of PAT for broader populations of people using MA. It is encouraging that this participant, a daily MA user, showed improvements in mood and cognition, in addition to abstinence from MA.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1490907"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in PsychiatryPub Date : 2024-12-05eCollection Date: 2024-01-01DOI: 10.3389/fpsyt.2024.1416009
Daria Pinakhina, Evgeny Kasyanov, Grigory Rukavishnikov, Andrey K Larin, Vladimir A Veselovsky, Alexander Rakitko, Nikholay Neznanov, Alexander Kibitov, Galina Mazo, Mykyta Artomov
{"title":"The effect size of rs521851 in the intron of MAGI2/S-SCAM on HADS-D scores correlates with EAT-26 scores for eating disorders risk.","authors":"Daria Pinakhina, Evgeny Kasyanov, Grigory Rukavishnikov, Andrey K Larin, Vladimir A Veselovsky, Alexander Rakitko, Nikholay Neznanov, Alexander Kibitov, Galina Mazo, Mykyta Artomov","doi":"10.3389/fpsyt.2024.1416009","DOIUrl":"https://doi.org/10.3389/fpsyt.2024.1416009","url":null,"abstract":"<p><p>An association between the <i>MAGI2</i> (<i>S-SCAM</i>) intron variant rs521851 and depression symptoms, as measured by the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), has been recently reported. The role of <i>MAGI2</i> in depression has been linked to disruptions in the gut-brain axis. In this study, we investigated the association between rs521851 and HADS-D scores in an independent cohort of 380 individuals, consisting of 238 patients with an ICD-10 diagnosis of depression and 142 healthy controls. The original association was replicated in the patient cohort but not in the control group. Further analysis revealed that the effect size of rs521851 on HADS-D scores was moderated by Eating Attitudes Test 26 (EAT-26) scores. In participants with an EAT-26 score of ≥20, the effect size of rs521851 on HADS-D was more than 20 times greater compared to those with an EAT-26 score of <20. These findings successfully replicate the original association signal for <i>MAGI2</i> and HADS-D, and highlight the role of <i>MAGI2</i> in gut-brain interactions.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"15 ","pages":"1416009"},"PeriodicalIF":3.2,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11656592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}